Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8239337 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 7 Pages |
Abstract
A partial metabolic response in the anal tumor as determined by post-therapy FDG-PET is predictive of significantly decreased progression-free and cause-specific survival after chemoradiotherapy for anal cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Julie K. M.D., Ph.D., Barry A. M.D., Farrokh M.D., Robert J. M.D., Ph.D., James W. M.D., Perry W. M.D.,